Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Objective: Lower limb lymphedema (LLL) is a common postoperative complication in patients with cervical cancer. Here, we analyzed the independent risk factors of LLL and constructed a nomogram prediction model for the early detection of LLL in postoperative cervical cancer patients.

Methods: A cross-sectional study was conducted at a tertiary hospital in China between January 2020 and December 2023. A univariate analysis was carried out to determine the risk factors possibly related to LLL, and a logistic regression analysis was utilized to determine the independent risk factors related to LLL. Area under the receiver-operating characteristic curve (AUC) calibration plots and decision curve analysis were used to assess the performance of the nomogram model.

Results: Independent predictors for LLL risk included body mass index, hypertension, urinary tract infection, number of lymph nodes dissected, radiotherapy, chemotherapy, and functional exercise frequency. The clinical prediction model was established based on the above seven risk factors and showed superior predictive power both in the training cohort (AUC = 0.861) and the validation cohort (AUC = 0.837). The nomogram was well-calibrated. The decision curve analysis demonstrated that the LLL risk nomogram was clinically applicable.

Conclusion: The model has good discrimination and accuracy for LLL risk assessment, which can provide a reference for individualized clinical prediction of the risk of LLL in postoperative cervical cancer patients. Multicenter prospective trials are required to verify the predictive value of the model.

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijgo.70423DOI Listing

Publication Analysis

Top Keywords

cervical cancer
16
risk factors
16
prediction model
12
postoperative cervical
12
factors lll
12
lll risk
12
risk
9
lll
9
lower limb
8
limb lymphedema
8

Similar Publications

The Future of Cervical Cancer Screening Is Now.

Obstet Gynecol

July 2025

Ana I. Tergas is from the Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Health, Rutgers New Jersey Medical School, Newark, New Jersey. Mark H. Einstein is from the Department of Obstetrics, Gynecology, and Women's Health, Albert Einstein College of Medicine

View Article and Find Full Text PDF

Antibody-drug conjugates (ADCs) represent a promising therapeutic approach in gynecologic cancers, particularly ovarian and cervical malignancies. Agents such as mirvetuximab soravtansine, and tisotumab vedotin, targeting folate receptor alpha and tissue factor, respectively, reported clinical efficacy in patients with limited options. However, their use is associated with ocular toxicities, including keratopathy, blurred vision, and dry eye, which may impact adherence and quality of life.

View Article and Find Full Text PDF

Pterostilbene as a promising natural anticancer agent in gynecological cancers.

Med Oncol

September 2025

Department of Pharmacognosy, Faculty of Pharmacy, Mansoura University, Mansoura, 35516, Egypt.

Gynecological cancer, encompassing cancers such as endometrial and cervical cancer, is a growing concern worldwide, with a rising incidence and significant impact on women's health. Pterostilbene (PT), a natural compound, has shown promising therapeutic potential in gynecological cancer treatment. This review aims to summarize the current state of knowledge on PT's effects in gynecological cancer, focusing on its molecular mechanisms, preclinical studies, and clinical trials.

View Article and Find Full Text PDF

Background: High-dose-rate (HDR) brachytherapy is essential in the treatment of locally advanced cervical cancer. While Iridium-192 (Ir-192) is commonly used, its short half-life imposes logistical and financial constraints, particularly in low- and middle-income countries (LMICs). Cobalt-60 (Co-60), with a longer half-life and lower operational costs, is a viable alternative.

View Article and Find Full Text PDF

Human papillomavirus (HPV) causes multiple diseases in both sexes. This study evaluates the cost-effectiveness and epidemiological impact - defined as reductions in HPV-related disease cases - of a gender-neutral vaccination (GNV) strategy in China's economically developed metropolises: Beijing, Shanghai, and Guangzhou. A discrete-time Markov model simulated no vaccination, female-only vaccination (FOV), and GNV strategies among 12-year-olds.

View Article and Find Full Text PDF